EveryLife Foundation comments to Food and Drug Administration (FDA) on setting recommendations for diversity plans that aim to increase clinical trial diversity
The EveryLife Foundation for Rare Diseases has become The RARE Foundation! Read more about our new brand and how it unifies our advocacy work on behalf of the rare disease community.